Connection

Jérôme de Sèze to Neuromyelitis Optica

Back to Details
This is a "connection" page, showing publications Jérôme de Sèze has written about Neuromyelitis Optica.
Jérôme de Sèze
Connection Strength
1.960
Neuromyelitis Optica
  1. Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders. Eur J Neurol. 2021 Oct; 28(10):3461-3466.
    View in: PubMed
    Score: 0.589
  2. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder. Curr Opin Neurol. 2019 02; 32(1):111-114.
    View in: PubMed
    Score: 0.520
  3. Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options. Drugs. 2019 Feb; 79(2):125-142.
    View in: PubMed
    Score: 0.520
  4. [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing]. Nervenarzt. 2018 Dec; 89(12):1388-1399.
    View in: PubMed
    Score: 0.128
  5. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder. Rev Neurol (Paris). 2018 Dec; 174(10):675-679.
    View in: PubMed
    Score: 0.127
  6. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler. 2011 Sep; 17(9):1067-73.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.